Polyamine involvement in the secretion and action of TGF-α in hormone sensitive human breast cancer cells in culture

Inkyo Kim, Andrea Manni, James Lynch, Laurence Demers

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

These experiments were designed to test polyamine (PA)* involvement in the secretion and action of transforming growth factor α (TGF-α) in hormone responsive MCF-7 breast cancer cells in liquid culture. At the same time, we evaluated the influence of culture conditions (with serum vs. serum depleted) and subclonality of MCF-7 cells on PA involvement in estrogen (E2) and TGF-α stimulated cell proliferation. Despite inducing a profound suppression of cellular PA levels and inhibiting basal and E2-stimulated growth, administration of the PA synthesis inhibitor α-difluoromethylornithine (DFMO) did not influence either basal or E2-induced TGF-α secretion. In the same experiments, on the other hand, addition of DFMO completely blocked the growth stimulatory effect of exogenous TGF-α. However, when the culture conditions were changed to serum-free medium, TGF-α and E2-induced cell proliferation was affected modestly or not at all by DFMO administration, despite similar suppression of cellular ornithine decarboxylase (ODC) activity and PA levels. In addition, different clones of MCF-7 cells differed in their sensitivity to the antiproliferative effect of DFMO as well as in basal levels of ODC activity and PA. We conclude that PAs are not involved in basal or E2-stimulated TGF-α secretion in MCF-7 breast cancer cells. On the other hand, PAs do seem to be important mediators of TGF-α and E2-induced breast cancer cell proliferation, though the degree of such involvement appears to be influenced by serum factors and clonal variability of MCF-7 cells.

Original languageEnglish (US)
Pages (from-to)83-91
Number of pages9
JournalBreast Cancer Research and Treatment
Volume18
Issue number2
DOIs
StatePublished - May 1 1991

Fingerprint

Polyamines
Transforming Growth Factors
Eflornithine
Cell Culture Techniques
Hormones
Breast Neoplasms
MCF-7 Cells
Ornithine Decarboxylase
Cell Proliferation
Serum
Serum-Free Culture Media
Growth
Estrogens
Clone Cells

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{74754f99116143078b150ca22d4fbc78,
title = "Polyamine involvement in the secretion and action of TGF-α in hormone sensitive human breast cancer cells in culture",
abstract = "These experiments were designed to test polyamine (PA)* involvement in the secretion and action of transforming growth factor α (TGF-α) in hormone responsive MCF-7 breast cancer cells in liquid culture. At the same time, we evaluated the influence of culture conditions (with serum vs. serum depleted) and subclonality of MCF-7 cells on PA involvement in estrogen (E2) and TGF-α stimulated cell proliferation. Despite inducing a profound suppression of cellular PA levels and inhibiting basal and E2-stimulated growth, administration of the PA synthesis inhibitor α-difluoromethylornithine (DFMO) did not influence either basal or E2-induced TGF-α secretion. In the same experiments, on the other hand, addition of DFMO completely blocked the growth stimulatory effect of exogenous TGF-α. However, when the culture conditions were changed to serum-free medium, TGF-α and E2-induced cell proliferation was affected modestly or not at all by DFMO administration, despite similar suppression of cellular ornithine decarboxylase (ODC) activity and PA levels. In addition, different clones of MCF-7 cells differed in their sensitivity to the antiproliferative effect of DFMO as well as in basal levels of ODC activity and PA. We conclude that PAs are not involved in basal or E2-stimulated TGF-α secretion in MCF-7 breast cancer cells. On the other hand, PAs do seem to be important mediators of TGF-α and E2-induced breast cancer cell proliferation, though the degree of such involvement appears to be influenced by serum factors and clonal variability of MCF-7 cells.",
author = "Inkyo Kim and Andrea Manni and James Lynch and Laurence Demers",
year = "1991",
month = "5",
day = "1",
doi = "10.1007/BF01980970",
language = "English (US)",
volume = "18",
pages = "83--91",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

Polyamine involvement in the secretion and action of TGF-α in hormone sensitive human breast cancer cells in culture. / Kim, Inkyo; Manni, Andrea; Lynch, James; Demers, Laurence.

In: Breast Cancer Research and Treatment, Vol. 18, No. 2, 01.05.1991, p. 83-91.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Polyamine involvement in the secretion and action of TGF-α in hormone sensitive human breast cancer cells in culture

AU - Kim, Inkyo

AU - Manni, Andrea

AU - Lynch, James

AU - Demers, Laurence

PY - 1991/5/1

Y1 - 1991/5/1

N2 - These experiments were designed to test polyamine (PA)* involvement in the secretion and action of transforming growth factor α (TGF-α) in hormone responsive MCF-7 breast cancer cells in liquid culture. At the same time, we evaluated the influence of culture conditions (with serum vs. serum depleted) and subclonality of MCF-7 cells on PA involvement in estrogen (E2) and TGF-α stimulated cell proliferation. Despite inducing a profound suppression of cellular PA levels and inhibiting basal and E2-stimulated growth, administration of the PA synthesis inhibitor α-difluoromethylornithine (DFMO) did not influence either basal or E2-induced TGF-α secretion. In the same experiments, on the other hand, addition of DFMO completely blocked the growth stimulatory effect of exogenous TGF-α. However, when the culture conditions were changed to serum-free medium, TGF-α and E2-induced cell proliferation was affected modestly or not at all by DFMO administration, despite similar suppression of cellular ornithine decarboxylase (ODC) activity and PA levels. In addition, different clones of MCF-7 cells differed in their sensitivity to the antiproliferative effect of DFMO as well as in basal levels of ODC activity and PA. We conclude that PAs are not involved in basal or E2-stimulated TGF-α secretion in MCF-7 breast cancer cells. On the other hand, PAs do seem to be important mediators of TGF-α and E2-induced breast cancer cell proliferation, though the degree of such involvement appears to be influenced by serum factors and clonal variability of MCF-7 cells.

AB - These experiments were designed to test polyamine (PA)* involvement in the secretion and action of transforming growth factor α (TGF-α) in hormone responsive MCF-7 breast cancer cells in liquid culture. At the same time, we evaluated the influence of culture conditions (with serum vs. serum depleted) and subclonality of MCF-7 cells on PA involvement in estrogen (E2) and TGF-α stimulated cell proliferation. Despite inducing a profound suppression of cellular PA levels and inhibiting basal and E2-stimulated growth, administration of the PA synthesis inhibitor α-difluoromethylornithine (DFMO) did not influence either basal or E2-induced TGF-α secretion. In the same experiments, on the other hand, addition of DFMO completely blocked the growth stimulatory effect of exogenous TGF-α. However, when the culture conditions were changed to serum-free medium, TGF-α and E2-induced cell proliferation was affected modestly or not at all by DFMO administration, despite similar suppression of cellular ornithine decarboxylase (ODC) activity and PA levels. In addition, different clones of MCF-7 cells differed in their sensitivity to the antiproliferative effect of DFMO as well as in basal levels of ODC activity and PA. We conclude that PAs are not involved in basal or E2-stimulated TGF-α secretion in MCF-7 breast cancer cells. On the other hand, PAs do seem to be important mediators of TGF-α and E2-induced breast cancer cell proliferation, though the degree of such involvement appears to be influenced by serum factors and clonal variability of MCF-7 cells.

UR - http://www.scopus.com/inward/record.url?scp=0025780367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025780367&partnerID=8YFLogxK

U2 - 10.1007/BF01980970

DO - 10.1007/BF01980970

M3 - Article

C2 - 1912611

AN - SCOPUS:0025780367

VL - 18

SP - 83

EP - 91

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -